References
- Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63(4), 415–424 (2006).
- Thurston RC, Rewak M, Kubzansky LD. An anxious heart: anxiety and the onset of cardiovascular diseases. Prog. Cardiovasc. Dis. 55(6), 524–537 (2013).
- Vogelzangs N, Beekman AT, de Jonge P, Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Transl. Psychiatry 3, e249 (2013).
- Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J. Am. Coll. Cardiol. 56(1), 38–46 (2010).
- APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd Edition. Cambridge University Press, Washington, DC (1981).
- Phillips AC, Batty GD, Gale CR et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam experience study. Psychosom. Med. 71(4), 395–403 (2009).
- Roest AM, Zuidersma M, de Jonge P. Myocardial infarction and generalised anxiety disorder: 10-year follow-up. Br. J. Psychiatry 200(4), 324–329 (2012).
- Brietzke E, Kapczinski F, Grassi-Oliveira R, Grande I, Vieta E, McIntyre RS. Insulin dysfunction and allostatic load in bipolar disorder. Expert Rev. Neurother. 11(7), 1017–1028 (2011).
- Craig AD. Significance of the insula for the evolution of human awareness of feelings from the body. Ann. N. Y. Acad. Sci. 1225, 72–82 (2011).
- de Carvalho MR, Dias GP, Cosci F et al. Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects. Expert Rev. Neurother. 10(2), 291–303 (2010).
- Andersson U, Tracey KJ. Neural reflexes in inflammation and immunity. J. Exp. Med. 209(6), 1057–1068 (2012).
- Engler H, Doenlen R, Engler A et al. Acute amygdaloid response to systemic inflammation. Brain Behav. Immun. 25(7), 1384–1392 (2011).
- Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom. Med. 64(1), 15–28 (2002).
- Kamezaki Y, Katsuura S, Kuwano Y, Tanahashi T, Rokutan K. Circulating cytokine signatures in healthy medical students exposed to academic examination stress. Psychophysiology 49(7), 991–997 (2012).
- Godbout JP, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J. Neuroimmune Pharmacol. 1(4), 421–427 (2006).
- Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress. Anxiety 26(5), 447–455 (2009).
- Saavedra JM, S´anchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36(1), 1–18 (2011).
- Insel T, Cuthbert B, Garvey M et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 167(7), 748–751 (2010).
- Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis. Int. J. Cardiol. (2012).
- Cooper DC, Tomfohr LM, Milic MS et al. Depressed mood and flow-mediated dilation: a systematic review and meta-analysis. Psychosom. Med. 73(5), 360–369 (2011).